CLONAZEPAM | A075468 | RUBICON RESEARCH LTD
Highest NADAC/Unit
$0.0378
per ea
Lowest NADAC/Unit
$0.0199
per ea
Brand NDCs
0
Generic NDCs
16
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 72603030902CLONAZEPAM 2 MG TABLET | $0.0378 | EA | Generic | — | 2026-06-17 |
| 72888015405CLONAZEPAM 2 MG TABLET | $0.0378 | EA | Generic | — | 2026-06-17 |
| 72888015401CLONAZEPAM 2 MG TABLET | $0.0378 | EA | Generic | — | 2026-06-17 |
| 72603030901CLONAZEPAM 2 MG TABLET | $0.0378 | EA | Generic | — | 2026-06-17 |
| 72603030801CLONAZEPAM 1 MG TABLET | $0.0250 | EA | Generic | — | 2026-06-17 |
| 72603030802CLONAZEPAM 1 MG TABLET | $0.0250 | EA | Generic | — | 2026-06-17 |
Showing 6 of 16 NDCs.
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.